Ottimo raises $140mn in pursuit of ‘$100bn market’ for new cancer drugs
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Ottimo Pharma, which is developing a new cancer drug, has completed one of the largest early-stage biotech fundraisings of 2024 as …